Jennifer E Miller, PhD
Associate Professor of Medicine (General Medicine)Cards
About
Research
Publications
Featured Publications
The Critical Shortage of Iodinated Contrast Material — Will Value Prevail?
Tu LH, Miller JE, Forman HP. The Critical Shortage of Iodinated Contrast Material — Will Value Prevail? New England Journal Of Medicine 2022, 387: 491-493. PMID: 35704416, DOI: 10.1056/nejmp2206996.Peer-Reviewed Original ResearchEthical considerations in international clinical trial site selection.
Miller J, Millum J. Ethical considerations in international clinical trial site selection. BMJ Global Health 2022, 7 PMID: 35387769, PMCID: PMC8987699, DOI: 10.1136/bmjgh-2021-008012.Peer-Reviewed Original ResearchAccess to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
Ramachandran R, Ross JS, Miller JE. Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials. JAMA Network Open 2021, 4: e2134233. PMID: 34792596, PMCID: PMC8603077, DOI: 10.1001/jamanetworkopen.2021.34233.Peer-Reviewed Original ResearchEvaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Miller JE, Mello MM, Wallach JD, Gudbranson EM, Bohlig B, Ross JS, Gross CP, Bach PB. Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs. JAMA Network Open 2021, 4: e217075. PMID: 33950209, PMCID: PMC8100865, DOI: 10.1001/jamanetworkopen.2021.7075.Peer-Reviewed Original ResearchConceptsFDA approvalHigh-income countriesDrug approvalIncome countriesNovel drugsDrug Administration (FDA) drug approvalsRegulatory agency websitesCross-sectional analysisProportion of drugPrimary outcomeFDA drug approvalsProportion of countriesDrug trialsMAIN OUTCOMEUS FoodClinical researchCountry income levelLow-income countriesMarketing approvalTrialsGoogle ScholarDrugsDrug companiesApprovalMedian
2025
Toward Patient-Centered AI Fact Labels: Leveraging Extrinsic Trust Cues
Yoo D, Stroud A, Zhu X, Miller J, Barry B. Toward Patient-Centered AI Fact Labels: Leveraging Extrinsic Trust Cues. 2025, 2025: 676-690. PMID: 41019587, PMCID: PMC12461688, DOI: 10.1145/3715336.3735758.Peer-Reviewed Original ResearchExamining equity-related eligibility criteria in clinical trials supporting 2022 US drug approvals
Sliwinski K, Miller J, Lynch H. Examining equity-related eligibility criteria in clinical trials supporting 2022 US drug approvals. PLOS ONE 2025, 20: e0324807. PMID: 40560878, PMCID: PMC12194189, DOI: 10.1371/journal.pone.0324807.Peer-Reviewed Original ResearchConceptsFood and Drug AdministrationEligibility criteriaClinical trialsUS Food and Drug AdministrationDrug approvalFood and Drug Administration guidanceInstitutional review boardFood and Drug Administration's Center for Drug EvaluationDrug AdministrationCenter for Drug EvaluationReview boardDrug evaluationSocioeconomic statusTrialsTherapeutic biologicsEligibilityAgeApprovalMolecular entitiesPregnancyRepresentation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time.
Miller J, Pelletiers W, Gross C, Mello M, Ramachandran R, Schwartz J, Suttiratana S, Varma T, Ross J. Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time. JCO Oncology Practice 2025, op2400563. PMID: 40493876, PMCID: PMC12360498, DOI: 10.1200/op-24-00563.Peer-Reviewed Original ResearchFood and Drug AdministrationOncology therapeuticsLatino patientsBlack patientsTherapeutic approvalsOlder adultsRetrospective cross-sectional studyUS Food and Drug AdministrationTrial characteristicsMinoritized patientsUS patient populationSpot trialsPivotal trialsPatient demographicsPatient populationRepresentative patientsTrial enrollmentUS Census dataDrug AdministrationPatientsStudy of trialsTrialsOncologyWomenClinical trial diversityPatient information needs for transparent and trustworthy cardiovascular artificial intelligence: A qualitative study
Stroud A, Minteer S, Zhu X, Ridgeway J, Miller J, Barry B. Patient information needs for transparent and trustworthy cardiovascular artificial intelligence: A qualitative study. PLOS Digital Health 2025, 4: e0000826. PMID: 40258073, PMCID: PMC12011294, DOI: 10.1371/journal.pdig.0000826.Peer-Reviewed Original ResearchArtificial intelligenceInformation needsHealthcare AI systemsInformation deliveryPatients' information needsCalibrate trustTrustworthy implementationAI systemsAsynchronous online focus groupsPatient-centered engagementCore information needsOnline focus groupsAI toolsHealthcare experiencesModel documentationHealth systemCardiovascular careClinical encountersPatient careFocus groupsProvision informationQualitative studyAI useInformation patientsPatient informationCultivating Patient-Centered Healthcare Artificial Intelligence Transparency: Considerations for AI Documentation
Stroud A, Miller J, Barry B. Cultivating Patient-Centered Healthcare Artificial Intelligence Transparency: Considerations for AI Documentation. The American Journal Of Bioethics 2025, 25: 129-131. PMID: 39992835, DOI: 10.1080/15265161.2025.2457775.Peer-Reviewed Original Research
2024
Trustworthy and ethical AI-enabled cardiovascular care: a rapid review
Mooghali M, Stroud A, Yoo D, Barry B, Grimshaw A, Ross J, Zhu X, Miller J. Trustworthy and ethical AI-enabled cardiovascular care: a rapid review. BMC Medical Informatics And Decision Making 2024, 24: 247. PMID: 39232725, PMCID: PMC11373417, DOI: 10.1186/s12911-024-02653-6.Peer-Reviewed Original ResearchConceptsHealthcare provider perspectiveRisk of patient harmCardiovascular careProvider perspectiveAI-based medical devicesPatient harmLoss of patient autonomyLack of robust evidenceTrust barriersHealthcare inequalitiesImprove careHealthcare providersCitation chasingPerceived lack of transparencyHealthcare existPatient careEthical concernsIntegration of AIPatient autonomyPatient interestLiterature reviewPerceived lackPractice guidelinesCareStudy design
Academic Achievements & Community Involvement
News
News
- May 08, 2025Source: The New York Times
Can a Photograph Reveal Your Biological Age?
- February 27, 2023
Increasing Diversity in Clinical Trials: A Q&A With Jennifer Miller, PhD
- February 21, 2023Source: Yale News
Insights & Outcomes: Clinical trial data gaps and a universe of old milk
- February 15, 2023Source: Nature
FDA to require diversity plan for clinical trials
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
367 Cedar Street, Harkness 4th floor
New Haven, CT 06520
United States